Moreover, a cluster of CD133+/EpCAM1+ hepatoma cells, which have been considered liver CSCs, exhibited enhanced E2F7 expression compared with the CD133−EpCAM− cells (Fig. 6d). This evidence concerns the gene PROM1 and hepatocellular carcinoma.